Cardiac Troponin I and T Ratio and Risk of Cardiovascular or Non-Cardiovascular Events in a General Population

Marie de Bakker1, Paul Welsh2, Naveed Sattar2

  • 1British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom.

Clinical Chemistry
|February 19, 2025
PubMed

Insights

The cardiac troponin I/T ratio predicts cardiovascular death risk in the general population. A higher ratio indicates increased cardiovascular mortality, while a lower ratio suggests higher non-cardiovascular mortality risk.

Area of Science:

  • Biomarkers
  • Cardiovascular Disease
  • Prognostics

Background:

  • Cardiac troponin (cTn) I/T ratio may predict adverse outcomes in cardiovascular disease patients.
  • Prognostic value of cTn I/T ratio in the general population is unknown.

Purpose of the Study:

  • To investigate the association between the cTn I/T ratio and mortality outcomes in the general population.

Main Methods:

  • Calculated cTn I/T ratio in 8855 participants from the Generation Scotland Study.
  • Used multivariable cause-specific Cox proportional hazard models to assess associations with cardiovascular and non-cardiovascular death.

Main Results:

  • Higher cTn I/T ratio tertile associated with male sex, higher BMI, systolic blood pressure, and cardiovascular disease history.
  • Lower cTn I/T ratio tertile associated with smoking and diabetes.
  • Adjusted analysis showed cTn I/T ratio positively associated with cardiovascular death (aHR 1.16) and inversely with non-cardiovascular death (aHR 0.89).

Conclusions:

  • The cTn I/T ratio is associated with cardiovascular and non-cardiovascular death in the general population.
  • Further research is needed to understand mechanisms and clinical utility for guiding management.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
82
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
77
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41
Odds Ratio01:09

Odds Ratio

The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
97
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
110
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
112